Clinical application of noradrenaline spillover methodology: delineation of regional human sympathetic nervous responses.
The proportionality which in general exists between rates of sympathetic nerve firing and the overflow of noradrenaline into the venous drainage of an organ provides the experimental justification for the use of measurements of noradrenaline in plasma as a biochemical measure of sympathetic nervous function. Static measurements of noradrenaline plasma concentration have several limitations. One is the confounding influence of noradrenaline plasma clearance on plasma concentration. Other drawbacks include the distortion arising from antecubital venous sampling (this represents but one venous drainage, that of the forearm), and the inability to detect regional differentiation of sympathetic responses. Clinical regional noradrenaline spillover measurements, performed with infusions of radiolabelled noradrenaline and sampling from centrally placed catheters, and derived from regional isotope dilution, overcome these deficiencies. The strength of the methodology is that sympathetic nervous function may be studied in the internal organs not accessible to nerve recording with microneurography. Examples of the regionalization of human sympathetic responses disclosed include the preferential activation of the cardiac sympathetic outflow with mental stress, cigarette smoking, aerobic exercise, cardiac failure, coronary insufficiency, essential hypertension and in ventricular arrhythmias, and the preferential stimulation or inhibition of the renal sympathetic nerves with low salt diets and mental stress, and with exercise training, respectively. By application of the same principles, regional release of the sympathetic cotransmitters neuropeptide Y and adrenaline can be studied in humans. Cotransmitter release, however, is detected only with some difficulty. In restricted circumstances we find evidence of regional cotransmitter release to plasma, such as the release of neuropeptide Y from the heart at the very high rates of sympathetic nerve firing occurring with aerobic exercise, and cardiac adrenaline release also with exercise and after loading of the neuronal adrenaline pool by intravenous infusion of adrenaline.
Esler
M
M
Human Autonomic Function Laboratory, Baker Medical Research Institute, Melbourne, Australia.
D000818:Animals; D001145:Arrhythmias, Cardiac / Q000503:physiopathology; D015415:Biomarkers / Q000097:blood; D002624:Chemistry, Clinical / Q000379:methods*; D004295:Dihydroxyphenylalanine / Q000097:blood; D006321:Heart / Q000294:innervation / Q000502:physiology; D006801:Humans; D007668:Kidney / Q000294:innervation / Q000502:physiology; D008734:Methoxyhydroxyphenylglycol / Q000031:analogs & derivatives / Q000097:blood; D009638:Norepinephrine / Q000008:administration & dosage / Q000097:blood* / Q000502:physiology; D011865:Radioisotope Dilution Technique; D011868:Radioisotopes; D013312:Stress, Physiological / Q000097:blood / Q000503:physiopathology; D013564:Sympathetic Nervous System / Q000502:physiology*
D015415:Biomarkers; D011868:Radioisotopes; D008734:Methoxyhydroxyphenylglycol; D004295:Dihydroxyphenylalanine; C010117:3,4-dihydroxyphenylglycol; D009638:Norepinephrine